{
    "2020-11-21": [
        [
            {
                "time": "",
                "orginal_text": "4只股北向资金持有流通盘的比例超10%",
                "features": {
                    "keywords": [
                        "北向资金",
                        "持股比例",
                        "超10%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "26只个股遭北上资金亿元抢筹！有色再遭北上资金爆单买入，信号？",
                "features": {
                    "keywords": [
                        "北上资金",
                        "抢筹",
                        "有色金属",
                        "爆单买入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "有色金属",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "第三批国家集采药品全国落地！重压下，企业只能降价调价以求中标？",
                "features": {
                    "keywords": [
                        "国家集采",
                        "药品",
                        "降价",
                        "中标"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "对话康桥资本傅唯：三大原因坚定看好医药行业，头部效应将越来越明显",
                "features": {
                    "keywords": [
                        "康桥资本",
                        "医药行业",
                        "头部效应",
                        "看好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "恒瑞医药：海外拓展缓慢 创新非一蹴而就",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "海外拓展",
                        "创新",
                        "缓慢"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}